Recent studies revealed a single treatment with HDAC inhibitors used in combination with conventional chemotherapeutic agents exhibits significant anti-cancer effects16, 17, and increasing evidence suggests that HDAC inhibitors combined with MTAs synergise to inhibit cell proliferation and induce apoptosis17. Here, HDAC9 is linked to cancer.